论文部分内容阅读
本文报道了由日本中外制药生产的rhG－CSF(格拉诺赛特Granocyte)治疗肺癌化疗后白细胞减少及其不良反应。1 材料与方法1．1 临床资料t回顾性选自本院1996～1998年住院肺癌患者9例，均经组织学或细胞学证实，分别为鳞癌3例、小细胞未分化癌4例、腺癌2例，无严重的心、肝、肾器质
This article reported that rhG-CSF (Granocyte) produced by Japan Chugai Pharmaceutical Co., Ltd. treats leukopenia and its adverse reactions after chemotherapy in lung cancer. 1 Materials and methods 1.1 Clinical data t retrospectively selected from 9 patients admitted to our hospital from 1996 to 1998. All of them were confirmed by histology or cytology, including 3 cases of squamous cell carcinoma and 4 cases of small cell undifferentiated carcinoma. , adenocarcinoma in 2 cases, no serious heart, liver, kidney